LMTK2 and prostate carcinoma: The role of LMTK2 in prostate cancer is well established (Eeles et al., 2008; Guy et al., 2009; Waters et al., 2009; Harries et al., 2010; Wang et al., 2013; Shui et al., 2014; Shah and Bradbury, 2015a,b; Hao et al., 2016; Jiang et al., 2016).